Attached files
file | filename |
---|---|
EX-32.1 - VITASPRING BIOMEDICAL CO. LTD. | ex321.htm |
EX-31.2 - VITASPRING BIOMEDICAL CO. LTD. | ex312.htm |
EX-31.1 - VITASPRING BIOMEDICAL CO. LTD. | ex311.htm |
10-Q - VITASPRING BIOMEDICAL CO. LTD. | vsbc10qjuly2020.htm |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
In connection with this Quarterly Report of VitaSpring Biomedical Co., Ltd. (the Company), on Form 10-Q for the period ended July 31, 2020, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Chu Pao-Chi, Principal Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
Such Quarterly Report on Form 10-Q for the period ended July 31, 2020, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in such Quarterly Report on Form 10-Q for the period ended July 31, 2020, fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
|
Date: September 25, 2020 | By: | /s/ Chu Pao-Chi |
|
| | Chu Pao-Chi |
|
|
| Principal Financial Officer VitaSpring Biomedical Co., Ltd. |
|
| | | |